SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • November 6th, 2015 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of September 28, 2015 (the “Effective Date”) is entered into by and between Robert S. Fishman, Chief Medical Officer (“CMO”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
CONSULTING AGREEMENTConsulting Agreement • November 6th, 2015 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
This Agreement is made and entered into as of the 1st day of July, 2015 (the “Effective Date”) by and between Corcept Therapeutics Incorporated (“Corcept”), a Delaware corporation located at 149 Commonwealth Drive, Menlo Park, CA 94025, and Anne LeDoux (“Consultant”), an individual, located at 38568 Bent Palm Drive, Palm Desert, CA 92211.
